Category Archives: Tysabri

Featured Stories
Dozens Receive Nonsterile Simulated Saline Solution

Dozens-Receive-Nonsterile-Simulated-Saline-Solution

The FDA said last week that more than 40 patients had received intravenous simulated saline that was not sterile and was not intended for human use.

Read More

Image Source: wisegeek.com

Trial over Ethicon Transvaginal Mesh Begins in California

Pelvic mesh devices have become the subject of safety concerns in recent years amidst reports that they can cause serious, sometimes permanent injuries.

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker’s recent recall of two metal hip implant components, the Rejuvenate Modular and ABG II modular-neck hip stems, may have dealt a serious blow to one of the key arguments medical device manufacturers have made to defend their metal-on-metal hip replacements. Facing thousands of lawsuits, the makers of ...

Read More

Hip Replacement, Knee Implant Patients with Diabetes, Other Health Problems May Face Difficult Recoveries

Patients receiving hip replacement devices or knee implants may face a more complicated recovery if they are obese, or suffer from diabetes or other health woes. According to a new study published online in the journal Anesthesiology, at least 3% of all total hip or knee replacement patients will ...

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

Three Injured, Long Island Railroad Train Hits Car on Tracks

Three Injured When Long Island Railroad Train Hits Car on Tracks

Three people, including a train engineer, were injured on Wednesday when a Long Island Rail Road train hit a livery cab on the tracks west of Wyandanch station, LIRR officials said. LIRR spokesman Salvatore Arena said the driver of the Lincoln Town Car was taken to Good Samaritan Hospital Medical Center ...

Read More

Cancer Groups Call for E-cigarettes Regulation/Research

Two-Leading-Cancer-Groups-Issue-Call-for-Regulation-of-E-cigarettes-and-Research-on-Health-Risks

The American Society of Clinical Oncology & the American Association for Cancer Research called for government regulation & research of e-cigarettes on health effects.

Read More

Research Suggest Fracking Chemicals Can Pollute Aquifers

A new study suggests fluids used during the hydraulic fracturing (fracking) process could migrate through underground fractures and contaminate water aquifers.

Read More

Pradaxa not Fit for a Dog, Family of Alleged Pradaxa Bleeding Victim Claims

The family of a Texas woman who died just months before her 60th wedding anniversary believes she would be alive today were it not for Pradaxa (dabigatran). According to a report from the Houston Press, Pradaxa patient Loraine Franklin fell and hit her head last December, resulting in an intracranial ...

Read More

New Research Links Multiple Sclerosis Drug Tysabri to Fatal Brain Infection

A newly published report indicates that patients taking the multiple sclerosis drug Tysabri have a higher risk of developing a potentially fatal brain infection than previously thought. German and French researchers found that Tysabri (natalizumab), used to treat patients with … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals, Tysabri |

Anti-Drug Antibodies Allegedly Lead to MS Patient’s Death

A Swedish woman diagnosed with multiple sclerosis (MS) appears to have died after developing anti-Tysabri (natalizumab) antibodies, according to emerging research. The woman tested with what MedPage Today described as “significant neurological abnormalities” and very high titers of antibodies against … Continue reading

Posted in Pharmaceuticals, Tysabri |

New Tysabri PML Risk Factor Identified

The Food and Drug Administration has identified a new risk factor which could lead to the life-threatening brain infection known as progressive multifocal leukoencephalopathy (PML) associated with the use of the drug Tysabri. Tysabri is prescribed as a “last resort” … Continue reading

Posted in Pharmaceuticals, Tysabri |

FDA Announces Tysabri Label Update

Last week, the U.S. Food & Drug Administration (FDA) announced it was updating the label of < "http://www.yourlawyer.com/topics/overview/tysabri">Tysabri (natalizumab) to include additional information about the risk of progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection. According to a … Continue reading

Posted in Pharmaceuticals, Tysabri |

Tysabri Label Modified to Include More Brain Infection Data

< "http://www.yourlawyer.com/topics/overview/tysabri">Tysabri, the multiple sclerosis drug marketed by Biogen Idec Inc. and Elan Corp is having its label updated to include new data about the incidence of progressive multifocal leukoencephalopathy, or PML, a rare brain infection. According to a report … Continue reading

Posted in Tysabri |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.